Radiopharmaceuticals Market: How Advanced Radiotherapy, Molecular Imaging and Theranostics Technologies Are Driving Growth Through 2033
The global Radiopharmaceuticals Industry is expanding rapidly as healthcare providers increasingly adopt molecular imaging and targeted radionuclide therapies for cancer and other chronic diseases. Rising cancer incidence, precision medicine adoption, nuclear medicine infrastructure development, and advances in isotope production are strengthening demand for diagnostic and therapeutic radiopharmaceuticals. According to Business Market Insights, the Radiopharmaceuticals Market size was valued at US$ 12.43 Billion in 2025 and is projected to reach US$ 53.27 Billion by 2033, growing at a CAGR of 19.95% during 2026–2033. Technological advancement is continuously transforming the Radiopharmaceuticals Market through improved isotope production, molecular imaging, radioligand development, alpha and beta emitters, precision oncology, and advanced nuclear medicine infrastructure. Pharmaceutical and biotechnology companies are developing targeted radiopharmaceuticals that can identify spec...